Welcome to our dedicated page for DHGR news (Ticker: DHGR), a resource for investors and traders seeking the latest updates and insights on DHGR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DHGR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DHGR's position in the market.
Devonian Health Group (TSXV:GSD, OTCQB:DVHGF) announced a proposed underwritten public offering of common shares (and/or pre-funded warrants) and warrants, together with an expected listing of its common shares and warrants on the NYSE American under the symbols DHGR and DHGRW, respectively. The listing remains subject to final authorization of the company's application and ongoing compliance with exchange rules, and the Offering is subject to market conditions and regulatory approval, with size and pricing yet to be determined.
According to Devonian, its shares are expected to continue trading on the OTCQB until pricing of the Offering, after which OTCQB trading will terminate once the NYSE American listing is effective. The company has also reserved the symbol DHGR on the TSX Venture Exchange and intends to change its current symbol from GSD to DHGR at a later date. ThinkEquity is acting as sole book-running manager, and a registration statement has been filed with the SEC but is not yet effective; no securities will be offered or sold to investors resident in Québec or elsewhere in Canada in connection with this Offering.